WT1 and acute myeloid leukemia: A significant inverse correlation between miR‐15a/16‐1 and WT1 expression levels was described in AML, suggesting that miR‐15a/16‐1 may inhibit leukemic cell proliferation through the downregulation of the WT1 oncogene [39].